KRT20 and neoplasm: The other tumors lacked this organization to some degree (Figure 3), either by absence of nuclear β-Catenin (type B), absence of enhanced CK20 in the tumor center (type C), absence of decreased nuclear β-Catenin in the tumor center (type D), or absence of both nuclear β-Catenin and CK20 expression (type E).